Incyte Corp. (INCY)
98.82
-0.09
(-0.09%)
USD |
NASDAQ |
Dec 31, 16:00
98.77
-0.05
(-0.05%)
After-Hours: 20:00
Incyte Market Cap: 19.40B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 962.16B |
| Halozyme Therapeutics, Inc. | 7.914B |
| Pfizer Inc. | 141.60B |
| Bio-Techne Corp. | 9.163B |
| Regeneron Pharmaceuticals, Inc. | 81.13B |
Market Cap Related Metrics
| PE Ratio | 16.58 |
| PS Ratio | 4.085 |
| PEG Ratio | 0.0040 |
| Price to Book Value | 4.171 |
| Price to Free Cash Flow | 16.77 |
| Price | 98.82 |
| Earnings Yield | 6.03% |
| PEGY Ratio | 0.0040 |
| Operating PE Ratio | 15.65 |
| Normalized PE Ratio | 19.15 |